<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2604-1227</journal-id>
<journal-title><![CDATA[Revista mexicana de oftalmología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. mex. oftalmol]]></abbrev-journal-title>
<issn>2604-1227</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Oftalmología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2604-12272019000200056</article-id>
<article-id pub-id-type="doi">10.24875/rmoe.m19000060</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Diagnostic utility of optical coherence tomography in patients with demyelinating optic neuritis]]></article-title>
<article-title xml:lang="es"><![CDATA[Utilidad diagnóstica de la tomografía de coherencia óptica en pacientes con neuritis óptica desmielinizante]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ossa-Calderón]]></surname>
<given-names><![CDATA[Carolina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Polanía-Barón]]></surname>
<given-names><![CDATA[Eduardo J.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Forero]]></surname>
<given-names><![CDATA[Héctor D.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Quintero-Cusguen]]></surname>
<given-names><![CDATA[Patricia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jaimes]]></surname>
<given-names><![CDATA[Diego A.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Valenzuela]]></surname>
<given-names><![CDATA[Natalia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Universitario de La Samaritana E.S.E Ophthalmology Service ]]></institution>
<addr-line><![CDATA[Bogotá DC ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Universitario de La Samaritana E.S.E Neurology Service ]]></institution>
<addr-line><![CDATA[Bogotá DC ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad de La Sabana Faculty of Medicine ]]></institution>
<addr-line><![CDATA[Chia ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2019</year>
</pub-date>
<volume>93</volume>
<numero>2</numero>
<fpage>56</fpage>
<lpage>61</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2604-12272019000200056&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2604-12272019000200056&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2604-12272019000200056&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective: To determine differences in nerve fiber layer (NFL) thickness by Optical Coherence Tomography (OCT) in patients with neuromyelitis optica (NMO) and Multiple Sclerosis (MS)  Methods: Case series study in adult patients diagnosed with MS and NMO.  Results: The estimated median and interquartile range (IQR) for nerve fiber layer thickness in healthy subjects was 110 IQR (16) µm, in patients with MS was 94 (21) µm and in patients with NMO was 76.5 (61) µm. The differences between healthy and sick subjects were estimated, finding that the NFL thickness was significantly lower in absolute data: &#916; = 16 µm for healthy-MS and &#916; = 33.5 µm for healthy-NMO. Regarding the quadrants of retinal nerve fiber layer, it was found that the lower and upper quadrants have a greater loss of nerve fibers in both diseases.  Conclusions: Our study supports evidence related to the involvement of ganglion cell layer and NFL observed in patients with MS and NMO. This study confirms what has been reported in other studies, that NFL thickness is a measure that can help diagnose the compromise and severity of optic nerve involvement in these two demyelinating diseases, with patterns that help to differentiate between NMO and EM.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo: Determinar las diferencias en el grosor de la capa de las fibras nerviosas (CFN) por medio de la tomografía de coherencia óptica (OCT) en pacientes con neuromielitis óptica (NMO) y esclerosis múltiple (EM)  Métodos:: Estudio de serie de casos en pacientes adultos con diagnóstico de EM y NMO.  Resultados: La mediana estimada y el rango intercuartílico (RIQ) para el grosor de la CFN en personas sanas fue de 110 RIQ (16) µm, en los pacientes con EM fue de 94 (21) µm y en los pacientes con NMO fue de 76.5 (61) µm. Se estimaron las diferencias entre pacientes sanos y enfermos, y se encontró que el grosor de la CFN era significativamente inferior en datos absolutos: &#916; = 16 µm para sanos-EM y &#916; = 33.5 µm para sanos-NMO. Respecto a los cuadrantes de CFN, se encontró que los cuadrantes inferiores y superiores tienen mayor pérdida de fibras nerviosas en ambas enfermedades  Conclusiones: Nuestro estudio soporta evidencia relacionada con el compromiso de la capa de células ganglionares y CFN observado en pacientes con EM y NMO. Este estudio nos confirma lo reportado en otros estudios, que el grosor de la CFN es una medida que puede ayudar a diagnosticar el compromiso y la gravedad del nervio óptico que puede estar afectado en estas dos enfermedades desmielinizantes, con patrones en los que se puede diferenciar entre NMO y EM.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Neuromyelitis optica]]></kwd>
<kwd lng="en"><![CDATA[Multiple sclerosis]]></kwd>
<kwd lng="en"><![CDATA[Optic neuritis]]></kwd>
<kwd lng="en"><![CDATA[Tomography]]></kwd>
<kwd lng="en"><![CDATA[Optical coherence]]></kwd>
<kwd lng="en"><![CDATA[Nerve fibers]]></kwd>
<kwd lng="es"><![CDATA[Neuromielitis óptica]]></kwd>
<kwd lng="es"><![CDATA[Esclerosis múltiple]]></kwd>
<kwd lng="es"><![CDATA[Neuritis óptica]]></kwd>
<kwd lng="es"><![CDATA[Tomografía]]></kwd>
<kwd lng="es"><![CDATA[Coherencia óptica]]></kwd>
<kwd lng="es"><![CDATA[Fibras nerviosas]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kidd]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Multiple Sclerosis, An Autoimmune Inflammatory Disease: Prospects for its Integratiev Management]]></article-title>
<source><![CDATA[Altern Med Rev]]></source>
<year>2001</year>
<volume>6</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>26</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bennett]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[de Seze]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lana-Peixoto]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Palace]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Waldman]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Schippling]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography]]></article-title>
<source><![CDATA[Mult Scler]]></source>
<year>2015</year>
<volume>21</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>678-88</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moriarty]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Optic neuritis]]></article-title>
<source><![CDATA[Minn Med]]></source>
<year>1968</year>
<volume>51</volume>
<page-range>1259-63</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Balk]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
<name>
<surname><![CDATA[Coric]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Bijvank]]></surname>
<given-names><![CDATA[JAN]]></given-names>
</name>
<name>
<surname><![CDATA[Killestein]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Uitdehaag]]></surname>
<given-names><![CDATA[BMJ]]></given-names>
</name>
<name>
<surname><![CDATA[Petzold]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Retinal atrophy in relation to visual functioning and vision-related quality of life in patients with multiple sclerosis]]></article-title>
<source><![CDATA[Mult Scler]]></source>
<year>2018</year>
<volume>24</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>767-76</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kallenbach]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Frederiksen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Optical coherence tomography in optic neuritis and multiple sclerosis: A review]]></article-title>
<source><![CDATA[Eur J Neurol]]></source>
<year>2007</year>
<volume>14</volume>
<page-range>841-9</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reichel]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Ho]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Duker]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[OCT Units: Which One Is Right for Me?]]></article-title>
<source><![CDATA[Rev Ophthalmol]]></source>
<year>2009</year>
<volume>16</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>62</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oct]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<collab>System SLO</collab>
<source><![CDATA[Advanced OCT/SLO System]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Elong Ngono]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lepetit]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Reindl]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Garcia]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Guillot]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Genty]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis]]></article-title>
<source><![CDATA[J Immunol Res]]></source>
<year>2015</year>
<volume>2015</volume>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Toosy]]></surname>
<given-names><![CDATA[AT]]></given-names>
</name>
<name>
<surname><![CDATA[Mason]]></surname>
<given-names><![CDATA[DF]]></given-names>
</name>
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[DH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Optic neuritis]]></article-title>
<source><![CDATA[Lancet Neurol]]></source>
<year>2014</year>
<volume>13</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>83-99</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chiquete]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Navarro-bonnet]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ayala-armas]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Gutiérrez-gutiérrez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Solórzano-meléndez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-tapia]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neuromielitis óptica: actualización clínica]]></article-title>
<source><![CDATA[Rev Neurol]]></source>
<year>2010</year>
<volume>51</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>289-94</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lucchinetti]]></surname>
<given-names><![CDATA[CF]]></given-names>
</name>
<name>
<surname><![CDATA[Mandler]]></surname>
<given-names><![CDATA[RN]]></given-names>
</name>
<name>
<surname><![CDATA[Mcgavern]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Bruck]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Gleich]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Ransohoff]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica]]></article-title>
<source><![CDATA[Brain]]></source>
<year>2002</year>
<page-range>1450-61</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Charcot]]></surname>
<given-names><![CDATA[J-M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Histologie de la sclérose en plaques, leçon faite àl'hospice de la Salpêtrière par M]]></article-title>
<source><![CDATA[Charcot et recueillie par M. Bourneville]]></source>
<year>1887</year>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Klawiter]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2009</year>
<volume>72</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1077-82</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Peng]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Xu]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zhou]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Thickness of macular inner retinal layers and peripapillary retinal nerve fibre layer in neuromyelitis optica spectrum optic neuritis and isolated optic neuritis with one episode]]></article-title>
<source><![CDATA[Acta Ophthalmol]]></source>
<year>2017</year>
<volume>95</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>583-90</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Outteryck]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Majed]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Defoort-dhellemmes]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Vermersch]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis]]></article-title>
<source><![CDATA[Mult Scler]]></source>
<year>2015</year>
<volume>21</volume>
<numero>14</numero>
<issue>14</issue>
<page-range>1781-93</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Oh]]></surname>
<given-names><![CDATA[SY]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Analysis of spectral domain optical coherence tomography measurements in optic neuritis: differences in neuromyelitis optica, multiple sclerosis, isolated optic neuritis and normal healthy controls]]></article-title>
<source><![CDATA[Acta Ophthalmol]]></source>
<year>2014</year>
<volume>92</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>e57-65</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Balk]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
<name>
<surname><![CDATA[Petzold]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Current and future potential of retinal optical coherence tomography in multiple sclerosis with and without optic neuritis]]></article-title>
<source><![CDATA[Neurodegener Dis Manag]]></source>
<year>2014</year>
<volume>4</volume>
<numero>2014</numero>
<issue>2014</issue>
<page-range>165-76</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lamirel]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Newman]]></surname>
<given-names><![CDATA[NJ]]></given-names>
</name>
<name>
<surname><![CDATA[Biousse]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Optical coherence tofmography (OCT) in optic neuritis and multiple sclerosis]]></article-title>
<source><![CDATA[Rev Neurol (Paris) [Internet]]]></source>
<year>2010</year>
<volume>166</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>978-86</page-range><publisher-name><![CDATA[Elsevier Masson SAS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Balk]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz-Herranz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Albrecht]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Arnow]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gelfand]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Tewarie]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study]]></article-title>
<source><![CDATA[]]></source>
<year>2016</year>
<volume>263</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1323-31</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Petzold]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Optical Coherence Tomography to Assess Neurodegeneration in Multiple Sclerosis]]></article-title>
<source><![CDATA[Methods Mol Biol]]></source>
<year>2016</year>
<volume>1304</volume>
<page-range>131-41</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brandt]]></surname>
<given-names><![CDATA[AU]]></given-names>
</name>
<name>
<surname><![CDATA[Martinez-lapiscina]]></surname>
<given-names><![CDATA[EH]]></given-names>
</name>
<name>
<surname><![CDATA[Nolan]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Saidha]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Monitoring the Course of MS With Optical Coherence Tomography]]></article-title>
<source><![CDATA[Curr Treat Options Neurol]]></source>
<year>2017</year>
<volume>19</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>15</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
